Strong EZH2 expression was associated with increased tumor cell proliferation in many cancer types, including astrocytoma, breast cancer, prostate cancer, bladder cancer, hepatocellular carcinoma, colon cancer, lung cancer, and pancreatic cancer (20). Here, EZH2 is linked to neoplasm.